Keep up with the latest layoffs with our tracker. In today's news, Relay Therapeutics is letting go about 10% of its workforce. #layoffs #biopharma #biospace https://hubs.li/Q02Sd7rZ0
BioSpace
Internet News
West Des Moines, Iowa 118,333 followers
The leading source for biopharma news and jobs. Connecting industry pioneers with talented professionals.
About us
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
- Website
-
http://www.biospace.com/
External link for BioSpace
- Industry
- Internet News
- Company size
- 11-50 employees
- Headquarters
- West Des Moines, Iowa
- Type
- Privately Held
- Founded
- 1985
- Specialties
- biotech jobs, pharma jobs, biotech news, pharma news, and life sciences news
Locations
-
Primary
3001 Westown Pkwy
#101
West Des Moines, Iowa 50266, US
Employees at BioSpace
-
Greg Slabodkin
-
Dr. D. Martin Alexander Gershon, MD, JD, MPH
AI & Digital Health Innovation Keynote•Linkedin “Top Voice” Venture Capital, Entrepreneurship, & Fundraising•Techstars Sr EIR•Goldman…
-
Angela Gabriel
Content Manager (Life Sciences Careers) at BioSpace
-
Lori Ellis
Market Intelligence Advisor | Moderator | Professional Speaker
Updates
-
Relay Therapeutics is cutting its workforce to help streamline its research organization as it looks to complete its first large-scale, pivotal clinical trial. #layoffs #biotech #biospace https://hubs.li/Q02SbnJB0
Relay Therapeutics to Lay Off 10% of Workforce
biospace.com
-
Scaling GLP-1 manufacturing capacity remains a key priority for the pharma industry, to help supply catch up with the insatiable demand for weight loss drugs. #GLP-1 #obesitydrugs #mounjaro #wegovy #biospace https://hubs.ly/Q02S9GRs0
Obesity Drug Shortage Ends for Lilly, Continues for Novo as Industry Bolsters Manufacturing
biospace.com
-
Under the deal announced Friday, the Italian pharma will make an upfront payment of $825 million to Sanofi for global rights to a biologic for the treatment of cold agglutinin disease, with milestone payments of up to $250 million. #autoimmune #pharma #biospace https://hubs.li/Q02S8ZLM0
Sanofi Offloads Rare Autoimmune Drug to Recordati in Potential $1B Deal
biospace.com
-
While it isn’t clear what triggered the $82 million payment, the announcement comes a week after AbbVie said that its Parkinson’s disease candidate tavapadon—which it secured from the $8.7 billion acquisition of Cerevel—cleared a Phase III study. #parkinsons #biopharma #research #biospace https://hubs.li/Q02S8S7w0
AbbVie Trims Full-Year Earnings Guidance Due to R&D Milestone Costs
biospace.com
-
Opdivo’s approval for patients with resectable non-small cell lung cancer comes as the regulator recently raised concerns of overtreatment with this type of therapeutic regimen with platinum-doublet chemotherapy. #FDA #cancer #biospace https://hubs.li/Q02S8YMY0
BMS Wins FDA Nod for Perioperative Opdivo Regimen in NSCLC
biospace.com
-
While a JAMA study found a decline in mpox antibody responses after vaccination, a University of Oxford expert cautioned that there is still not enough evidence to determine if this decline also leads to waning protections. #mpox #vaccine #pharma #biospace https://hubs.li/Q02S8Mdd0
Bavarian Nordic’s Mpox Shot Shows Antibody Responses Wane After 6 to 12 Months: Study
biospace.com
-
Gilead Sciences is granting licenses to six companies to produce lenacapavir for pre-exposure prophylaxis, as well as for treating human immunodeficiency virus in heavily pre-treated adults with multidrug-resistant infections. #HIV #pharma #biospace https://hubs.li/Q02S0lqB0
Gilead Partners With Generics Developers to Provide HIV Drug to Low-Income Countries
biospace.com
-
The adjusted guidelines will provide drugmakers with more opportunities to engage with the Centers for Medicare and Medicaid Services regarding the initial maximum fair price offers, according to the agency. #medicare #medicaid #pharma #biospace https://hubs.li/Q02S0lDC0
CMS Releases Updated Medicare Drug Price Negotiation Guidance, Offers More Flexible Timeline
biospace.com
-
The Financial Times reported Thursday that WuXi AppTec is looking to sell its cell and gene therapy manufacturing unit, with facilities in Philadelphia, while WuXi Biologics wants to offload some of its production sites in Europe. #cellandgenetherapy #biotech #biospace https://hubs.li/Q02R_kt-0
WuXi Mulls Sale of Some US, European Operations: FT
biospace.com